These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 16998336)
1. Applications of bilateral vascularized femoral bone marrow transplantation for chimerism induction across the major histocompatibility (MHC) barrier: part II. Klimczak A; Agaoglu G; Carnevale KA; Siemionow M Ann Plast Surg; 2006 Oct; 57(4):422-30. PubMed ID: 16998336 [TBL] [Abstract][Full Text] [Related]
2. Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier. Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Yoder B; Siemionow M Transplant Proc; 2006 Jun; 38(5):1625-33. PubMed ID: 16797371 [TBL] [Abstract][Full Text] [Related]
3. Strategies to develop chimerism in vascularized skin allografts across MHC barrier. Demir Y; Ozmen S; Klimczak A; Mukherjee AL; Siemionow MZ Microsurgery; 2005; 25(5):415-22. PubMed ID: 16025439 [TBL] [Abstract][Full Text] [Related]
4. Different routes of donor-derived hematopoietic stem cell transplantation for donor-specific chimerism induction across MHC barrier. Siemionow MZ; Klimczak A; Unal S Transplant Proc; 2005; 37(1):62-4. PubMed ID: 15808547 [TBL] [Abstract][Full Text] [Related]
5. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol. Siemionow MZ; Izycki DM; Zielinski M Transplantation; 2003 Dec; 76(12):1662-8. PubMed ID: 14688512 [TBL] [Abstract][Full Text] [Related]
6. Role of thymus in operational tolerance induction in limb allograft transplant model. Siemionow M; Izycki D; Ozer K; Ozmen S; Klimczak A Transplantation; 2006 Jun; 81(11):1568-76. PubMed ID: 16770246 [TBL] [Abstract][Full Text] [Related]
7. Long-term survival of composite hemiface/mandible/tongue allografts correlates with multilineage chimerism development in the lymphoid and myeloid compartments of recipients. Kulahci Y; Klimczak A; Madajka M; Altuntas S; Siemionow M Transplantation; 2010 Oct; 90(8):843-52. PubMed ID: 20697324 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of transient treatment with FK506 in the early phase on cyclophosphamide-induced bone marrow chimerism and transplant tolerance across MHC barriers. Okayama J; Ko S; Kanehiro H; Kanokogi H; Nakajima Y J Surg Res; 2006 Jun; 133(2):61-8. PubMed ID: 16376943 [TBL] [Abstract][Full Text] [Related]
9. Bone marrow chimerism and tolerance induced by single-dose cyclophosphamide. Okayama J; Ko S; Kanehiro H; Kanokogi H; Hisanaga M; Ohashi K; Sho M; Nagao M; Ikeda N; Kanamura T; Akashi S; Nakajima Y J Surg Res; 2004 Jul; 120(1):102-10. PubMed ID: 15172196 [TBL] [Abstract][Full Text] [Related]
10. New composite tissue allograft model of vascularized bone marrow transplant: the iliac osteomyocutaneous flap. Nasir S; Klimczak A; Sonmez E; Bozkurt M; Gibson S; Siemionow M Transpl Int; 2010 Jan; 23(1):90-100. PubMed ID: 19686290 [TBL] [Abstract][Full Text] [Related]
11. Development of donor-specific chimerism and tolerance in composite tissue allografts under alphabeta-T-cell receptor monoclonal antibody and cyclosporine a treatment protocols. Ozer K; Izycki D; Zielinski M; Siemionow M Microsurgery; 2004; 24(3):248-54. PubMed ID: 15160385 [TBL] [Abstract][Full Text] [Related]
12. Donor bone marrow in laryngeal transplantation: results of a rat study. Khariwala SS; Dan O; Lorenz RR; Klimczak A; Siemionow M; Strome M Am J Otolaryngol; 2008; 29(4):242-9. PubMed ID: 18598835 [TBL] [Abstract][Full Text] [Related]
13. Chimerism induction in vascularized bone marrow transplants augmented with bone marrow cells. Arslan E; Klimczak A; Siemionow M Microsurgery; 2007; 27(3):190-9. PubMed ID: 17326192 [TBL] [Abstract][Full Text] [Related]
14. Bilateral vascularized femoral bone transplant: a new model of vascularized bone marrow transplantation in rats, part I. Agaoglu G; Carnevale KA; Zins JE; Siemionow M Ann Plast Surg; 2006 Jun; 56(6):658-64. PubMed ID: 16721081 [TBL] [Abstract][Full Text] [Related]
15. Composite vascularized skin/bone graft model: a viable source for vascularized bone marrow transplantation. Siemionow M; Ulusal BG; Ozmen S; Ulusal AE; Ozer K Microsurgery; 2004; 24(3):200-6. PubMed ID: 15160378 [TBL] [Abstract][Full Text] [Related]
16. Donor-origin cell engraftment after intraosseous or intravenous bone marrow transplantation in a rat model. Klimczak A; Unal S; Jankowska A; Coburn C; Siemionow M Bone Marrow Transplant; 2007 Aug; 40(4):373-80. PubMed ID: 17572707 [TBL] [Abstract][Full Text] [Related]
17. A new method of bone marrow transplantation leads to extension of skin allograft survival. Siemionow M; Ozer K; Izycki D; Unsal M; Klimczak A Transplant Proc; 2005 Jun; 37(5):2309-14. PubMed ID: 15964406 [TBL] [Abstract][Full Text] [Related]
18. Induction of donor-specific tolerance in rat hind-limb allografts under antilymphocyte serum and cyclosporine A protocol. Siemionow M; Oke R; Ozer K; Izycki D; Prajapati R J Hand Surg Am; 2002 Nov; 27(6):1095-103. PubMed ID: 12457363 [TBL] [Abstract][Full Text] [Related]
19. Flow cytometric analysis of chimerism in the rat tolerant to a renal allograft. Naar JD; Fisher RA; Saggi BH; Wakely PE; Tawes JW; Posner MP J Surg Res; 1998 Jul; 77(2):179-86. PubMed ID: 9733606 [TBL] [Abstract][Full Text] [Related]
20. Vascularized bone marrow transplantation: A new surgical approach using isolated femoral bone/bone marrow. Suzuki H; Patel N; Matthews M; DelRossi AJ; Doolin EJ; Hewitt CW J Surg Res; 2000 Apr; 89(2):176-83. PubMed ID: 10729247 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]